ADC Therapeutics SA (ADCT) vs Siga Technologies Inc. (SIGA)

ADC Therapeutics SA and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. ADC Therapeutics SA and Siga Technologies Inc. are of similar size ($213.4M and $209.4M). ADC Therapeutics SA grew revenue faster over the last twelve months: 3.03% against −70.1%. Siga Technologies Inc. has the higher net margin (−5.19% vs −121.8%) and the lower return on invested capital (−14.6% vs 0.00%). Across the 18 metrics below, ADC Therapeutics SA leads on 10 and Siga Technologies Inc. on 8.

Valuation

Metric ADCT SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 3.23 3.97 2.08
P/B n/m 1.29 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.95 4.74 2.87
Earnings yield (39.76%) (1.35%) (15.94%)
Free cash flow yield (39.53%) (9.63%) 0.00%

Profitability

Metric ADCT SIGA Drug Manufacturers Specialty & Generic median
Gross margin 88.86% 54.35% 53.51%
Operating margin (125.08%) (20.76%) 0.00%
Net margin (121.77%) (5.19%) (2.45%)
Free cash flow margin (127.72%) (37.58%) 0.00%
Return on equity 45.35% (1.49%) (0.80%)
Return on assets (32.25%) (1.36%) (1.67%)
Return on invested capital 0.00% (14.59%) 0.00%

Growth

Metric ADCT SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 3.03% (70.13%) 5.22%
EPS growth (last fiscal year) 30.86% (60.98%) 42.91%
Revenue growth, 5-year CAGR 103.35% (5.42%) 7.24%
Net income growth, 5-year CAGR 0.00% (16.20%) 0.00%

Health

Metric ADCT SIGA Drug Manufacturers Specialty & Generic median
Debt to equity (0.51) 0.00 0.04
Current ratio 3.03 21.72 2.41
Net debt to EBITDA 1.22 (6.39) 1.01

Dividend

Metric ADCT SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.45%
Payout ratio — — 0.27

Size

Metric ADCT SIGA Drug Manufacturers Specialty & Generic median
Market cap 209.38m 213.40m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack